← Back to Analyst Consensus 
SION Hold
Sionna Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 17
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 15, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| Aug 11, 2026 | Guggenheim | downgrade | Buy → Neutral | — | 52% |
| Aug 11, 2026 | Wedbush | downgrade | Outperform → Neutral | — | 58% |
| Aug 10, 2026 | BTIG | downgrade | Buy → Neutral | — | 52% |
| Aug 7, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| May 26, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| May 20, 2026 | Freedom Broker | downgrade | Buy → Hold | — | 59% |
| May 18, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| May 13, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| May 5, 2026 | Wedbush | initiate | — → Outperform | — | 58% |
| Apr 28, 2026 | Jones Trading | maintain | Buy → Buy | — | 50% |
| Apr 27, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Mar 3, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Mar 2, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Feb 24, 2026 | Citizens | initiate | — → Market Outperform | $63 | 47% |
| Jan 14, 2026 | BTIG | reiterate | Buy → Buy | $58 | 52% |
| Jan 7, 2026 | BTIG | maintain | Buy → Buy | $58 | 52% |
| Dec 23, 2025 | LifeSci Capital | initiate | — → Outperform | $60 | 57% |
| Dec 1, 2025 | RBC Capital | downgrade | Sector Perform → Underperform | $24 | 55% |
| Nov 19, 2025 | BTIG | initiate | — → Buy | $50 | 52% |
| Oct 17, 2025 | Freedom Capital Markets | initiate | — → Buy | $38 | 43% |
| Sep 8, 2025 | Jones Trading | initiate | — → Buy | $46 | 50% |
| Sep 3, 2025 | Raymond James | initiate | — → Strong Buy | $45 | 54% |
| Sep 3, 2025 | RBC Capital | initiate | — → Sector Perform | $22 | 55% |
| Mar 4, 2025 | Stifel | initiate | — → Buy | $32 | 53% |
Price Target Trend
Jul 13, 2026 Latest: $21 Oct 25, 2026
EPS Estimates
+1q $-0.55
Lo: $-0.68 Hi: $-0.37
8 analysts ▲3
+1y $-2.23
Lo: $-3.18 Hi: $-1.24
10 analysts ▲3
0y $-2.45
Lo: $-2.64 Hi: $-1.93
10 analysts ▲2
0q $-0.68
Lo: $-0.84 Hi: $-0.53
8 analysts ▲2
Cross-Platform Signals
No cross-platform signals in the last 90 days